07:00 , May 16, 2011 |  BC Week In Review  |  Company News

Aegis Therapeutics, Albany Medical College deal

Aegis and the college partnered to create an oral formulation of the college's breast cancer candidate AFPep using Aegis' Intravail transmucosal intranasal drug delivery technology. Aegis, which said it is in discussions with oncology...
08:00 , Feb 11, 2002 |  BC Week In Review  |  Company News

Albany Medical College other research news

Scientists reported in the Proceedings of the National Academy of Sciences that AFPep treatment significantly reduced the growth of both tamoxifen responsive and nonresponsive estrogen-dependent breast cancer xenografts in a mouse model (p<0.05 for both)....